Stanley Druckenmiller Ac Immune Sa Transaction History

Duquesne Family Office LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$4.72 - $5.88 $6.25 Million - $7.79 Million	-1,324,935 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$3.65 - $11.68 $4.26 Million - $13.6 Million	-1,166,582 Reduced 46.82%	1,324,935 $6.69 Million
Q3 2018 Nov 14, 2018	BUY	$7.88 - $16.45 $810,197 - $1.69 Million	102,817 Added 4.3%	2,491,517 $19.9 Million
Q3 2017 Nov 14, 2017	BUY	$7.06 - $11.2 $16.9 Million - $26.8 Million	2,388,700	2,388,700 $27 Million

28.2M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $224M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Duquesne Family Office LLC, based on Form 13F filings with the SEC.

Stay updated on Duquesne Family Office LLC and Stanley Druckenmiller with notifications on news.